Business Daily Media

Business Marketing

.

SinoMab, Sinovent and Everest Medicines Announce Licensing Agreement for Global Development and Commercialization of A Next-Generation BTK Inhibitor in Renal Diseases

  • Written by ACN Newswire - Press Releases
HONG KONG, Sep 17, 2021 - (ACN Newswire) - SinoMab BioScience Limited (HKEX 3681.HK, "SinoMab") announced with Suzhou Sinovent Pharmaceuticals Co., Ltd. ("Sinovent") today that they have entered into an exclusive licensing agreement with Everest Medicines (HKEX 1952.HK, "Everest") to out-license the right to develop and commercialize SN1011

Read more //?#

Popular

Australian businesses better positioned to tackle the skills gap than global competitors

KellyOCG survey points to agility as differentiator for Australian organizations, identifies key challenges for business leaders  SYDNEY. (July 21, 2021) – Australian businesses may be in a better position than global competi...

Accenture to Acquire Solnet to Expand Cloud First Capabilities in Aotearoa New Zealand

Accenture (NYSE: ACN) has agreed to acquire Solnet, an IT services provider with deep technology consulting experience for New Zealand government and private organizations across multiple industries. Terms of the transaction w...

From passion projects to a thriving business: small business tips from Cardigang

Starting a small business from scratch requires a number of skills, arguably some of the most important include resilience, optimism, and passion. Cat Bloxsom and Morgan Collins encompass these qualities. During Melbourne’s lo...

Virtual Office
Tomorrow Business Growth